Avidity Biosciences Stock Price on January 23, 2025

RNA Stock  USD 31.12  1.41  4.33%   
Below is the normalized historical share price chart for Avidity Biosciences extending back to June 12, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Avidity Biosciences stands at 31.12, as last reported on the 21st of February, with the highest price reaching 33.21 and the lowest price hitting 31.06 during the day.
IPO Date
28th of June 2013
200 Day MA
38.4747
50 Day MA
31.9164
Beta
1.001
 
Covid
If you're considering investing in Avidity Stock, it is important to understand the factors that can impact its price. Avidity Biosciences secures Sharpe Ratio (or Efficiency) of -0.18, which signifies that the company had a -0.18 % return per unit of risk over the last 3 months. Avidity Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Avidity Biosciences' Standard Deviation of 3.64, mean deviation of 2.71, and Risk Adjusted Performance of (0.12) to double-check the risk estimate we provide.
  
At present, Avidity Biosciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 1.3 B, whereas Common Stock is forecasted to decline to 6,840. . At present, Avidity Biosciences' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.29, whereas Price To Sales Ratio is forecasted to decline to 75.51. Avidity Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1849

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRNA

Estimated Market Risk

 3.14
  actual daily
27
73% of assets are more volatile

Expected Return

 -0.58
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.18
  actual daily
0
Most of other assets perform better
Based on monthly moving average Avidity Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avidity Biosciences by adding Avidity Biosciences to a well-diversified portfolio.
Price Book
2.5316
Enterprise Value Ebitda
(5.72)
Price Sales
383.6238
Shares Float
91.8 M
Wall Street Target Price
67.9091

Avidity Biosciences Main Headline on 23rd of January 2025

Filed transaction by Avidity Biosciences Officer Chief Human Resources Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Avidity Biosciences Valuation on January 23, 2025

It is possible to determine the worth of Avidity Biosciences on a given historical date. On January 23, 2025 Avidity was worth 30.0 at the beginning of the trading date compared to the closed value of 30.13. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Avidity Biosciences stock. Still, in general, we apply an absolute valuation method to find Avidity Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avidity Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Avidity Biosciences' related companies.
 Open High Low Close Volume
  30.90    31.87    29.51    30.08    1,248,191  
01/23/2025
  30.00    30.62    29.05    30.13    1,145,046  
  29.72    30.13    29.23    29.67    1,127,908  
Backtest Avidity Biosciences  |  Avidity Biosciences History  |  Avidity Biosciences Valuation PreviousNext  
Open Value
30.0
30.13
Closing Value
39.41
Upside

Avidity Biosciences Trading Date Momentum on January 23, 2025

On January 24 2025 Avidity Biosciences was traded for  29.67  at the closing time. Highest Avidity Biosciences's price during the trading hours was 30.13  and the lowest price during the day was  29.23 . The net volume was 1.1 M. The overall trading history on the 24th of January contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 1.53% . The overall trading delta to current price is 4.65% .
JavaScript chart by amCharts 3.21.1501/23/2025Jan 13Jan 15Jan 17Jan 19Jan 21Jan 23Jan 25Jan 27Jan 29Jan 3127282930313233

Avidity Biosciences Fundamentals Correlations and Trends

By evaluating Avidity Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Avidity Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Avidity financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Avidity Biosciences Stock history

Avidity Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Avidity is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Avidity Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Avidity Biosciences stock prices may prove useful in developing a viable investing in Avidity Biosciences
Last ReportedProjected for Next Year
Common Stock Shares Outstanding84 M45.2 M
Net Loss-156.6 M-148.8 M

Avidity Biosciences Quarterly Net Working Capital

1.53 Billion

100%

Avidity Biosciences Stock Technical Analysis

Avidity Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Avidity Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Avidity Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Avidity Biosciences Period Price Range

Low
February 21, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Avidity Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Avidity Biosciences February 21, 2025 Market Strength

Market strength indicators help investors to evaluate how Avidity Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avidity Biosciences shares will generate the highest return on investment. By undertsting and applying Avidity Biosciences stock market strength indicators, traders can identify Avidity Biosciences entry and exit signals to maximize returns

Avidity Biosciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Avidity Biosciences' price direction in advance. Along with the technical and fundamental analysis of Avidity Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Avidity to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Avidity Stock analysis

When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital

Trending Assets

CGEM
Cullinan Oncology LLC
9.43  0.17  1.84 
MLYS
Mineralys Therapeutics,
9.32  -0.28  -2.92 
BDTX
Black Diamond Therap
2.28  -0.09  -3.8 
RLAY
Relay Therapeutics
4.09  -0.07  -1.68